BAVARIAN NOR NAM. DK 10/ DK0015998017 /
2024-04-18 9:43:47 PM | Chg. -0.275 | Volume | Bid9:55:41 PM | Ask9:55:41 PM | High | Low |
---|---|---|---|---|---|---|
19.675EUR | -1.38% | 358 Turnover: 7,031.805 |
19.460Bid Size: 255 | 19.710Ask Size: 255 | 19.950 | 19.360 |
GlobeNewswire
02-23
Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines...
GlobeNewswire
2022-03-21
Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Com...
GlobeNewswire
2022-02-28
Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead...
GlobeNewswire
2022-02-14
Bavarian Nordic Announces Breakthrough Therapy Designation for its RSV Vaccine Candidate for the Pre...
GlobeNewswire
2021-12-06
Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening it...
GlobeNewswire
2021-12-05
Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate
GlobeNewswire
2021-09-01
Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate
GlobeNewswire
2021-08-23
Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of CO...
GlobeNewswire
2021-08-23
Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine
GlobeNewswire
2021-08-09
Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine
GlobeNewswire
2021-06-11
Bavarian Nordic Assists Public Health England in Response to New Cases of Monkeypox
GlobeNewswire
2021-03-08
Bavarian Nordic Reports Encouraging Preclinical Data for COVID-19 Vaccine Candidate Ahead of First-i...
GlobeNewswire
2020-12-16
Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government
GlobeNewswire
2020-08-24
Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Small...
GlobeNewswire
2020-07-22
Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 Vaccine
GlobeNewswire
2020-07-01
Bavarian Nordic Announces European Marketing Authorization for Ebola Vaccine